SEC Form 4 · accession 0001683168-17-000141
MEDICINOVA INC · MNOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Masatsune Okajima
Officer — VP and Head of Japanese Office
Period of report
Jan 18, 2017
Accepted (ET)
Jan 20, 2017 · 5:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001226616
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $3.91 | Jan 18, 2017 | A | 120,000 | A | Jan 18, 2017 | Jan 6, 2026 | Common Stock | 120,000 | 120,000 | D |
Explanation of responses
- F1On January 7, 2016, the reporting person was granted an option to purchase 120,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria by December 31, 2016. The Performance criteria have been met, resulting in full vesting of the option.